Literature DB >> 7615741

Reappraisal with meta-analysis of bacteremia, endotoxemia, and mortality in gram-negative sepsis.

J C Hurley1.   

Abstract

Among patients with suspected sepsis, endotoxemia is variably present in association with gram-negative bacteremia. A total of 738 patients with suspected sepsis from 11 studies could be classified into four groups: 131 (18%) patients had both endotoxemia and gram-negative bacteremia (group 1), 87 (12%) had only gram-negative bacteremia (group 2), and 143 (19%) had only endotoxemia (group 3); in 377 (51%) patients neither could be detected (group 4). By the statistical techniques of meta-analysis, the fatality risk for patients with either endotoxemia or gram-negative bacteremia or both was estimated with group-specific case fatality rates from these studies and expressed as an odds ratio (OR; 95% confidence interval [95% CI]) versus patients with these factors absent. This risk was increased marginally when endotoxemia was detected without gram-negative bacteremia (OR, 2.3; 95% CI, 1.3 to 4.0) or the converse (OR, 2.0; 95% CI, 1.0 to 3.8), in contrast to the striking increase when both endotoxemia and gram-negative bacteremia were detected (OR, 6.3; 95% CI, 4.0 to 10.0). Alone, neither endotoxemia nor gram-negative bacteremia is a strong predictor of outcome in patients with suspected sepsis. However, in combination, the two identify a subpopulation with a substantially increased risk of mortality.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615741      PMCID: PMC228145          DOI: 10.1128/jcm.33.5.1278-1282.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  Can meta-analyses be trusted?

Authors:  S G Thompson; S J Pocock
Journal:  Lancet       Date:  1991-11-02       Impact factor: 79.321

Review 2.  Sepsis management and antiendotoxin therapy after nebacumab. A reappraisal.

Authors:  J C Hurley
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

3.  Clinical experience on the detection of endotoxemia with the limulus test.

Authors:  L A Martinez; R Quintiliani; R C Tilton
Journal:  J Infect Dis       Date:  1973-01       Impact factor: 5.226

4.  Diagnostic and prognostic significance of plasma endotoxin determination in febrile patients with haematological malignancies.

Authors:  M Yoshida; T Obayashi; H Tamura; S Tanaka; T Kawai; S Sakamoto; Y Miura
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

5.  Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock.

Authors:  R L Danner; C Natanson; R J Elin; J M Hosseini; S Banks; T J MacVittie; J E Parrillo
Journal:  Chest       Date:  1990-12       Impact factor: 9.410

6.  Yersinia pestis infection in Vietnam. II. Quantiative blood cultures and detection of endotoxin in the cerebrospinal fluid of patients with meningitis.

Authors:  T Butler; J Levin; N N Linh; D M Chau; M Adickman; K Arnold
Journal:  J Infect Dis       Date:  1976-05       Impact factor: 5.226

7.  Alterations of bacterial clearance induced by endotoxin and tumor necrosis factor.

Authors:  T Koch; H P Duncker; R Axt; H G Schiefer; K van Ackern; H Neuhof
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

8.  Endotoxaemia in septic shock: clinical and post mortem correlations.

Authors:  A C McCartney; J G Banks; G B Clements; J D Sleigh; M Tehrani; I M Ledingham
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

9.  Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels.

Authors:  C H Wortel; M A von der Möhlen; S J van Deventer; C L Sprung; M Jastremski; M J Lubbers; C R Smith; I E Allen; J W ten Cate
Journal:  J Infect Dis       Date:  1992-12       Impact factor: 5.226

Review 10.  Endotoxemia: methods of detection and clinical correlates.

Authors:  J C Hurley
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

View more
  6 in total

1.  Quantitative lipopolysaccharide analysis using HPLC/MS/MS and its combination with the limulus amebocyte lysate assay.

Authors:  Jean-Paul Pais de Barros; Thomas Gautier; Wahib Sali; Christophe Adrie; Hélène Choubley; Emilie Charron; Caroline Lalande; Naig Le Guern; Valérie Deckert; Mehran Monchi; Jean-Pierre Quenot; Laurent Lagrost
Journal:  J Lipid Res       Date:  2015-05-28       Impact factor: 5.922

2.  Sedimentation characteristics of leucocytes can predict bacteraemia in critical care patients.

Authors:  L Bogar; Z Molnar; P Kenyeres; P Tarsoly
Journal:  J Clin Pathol       Date:  2006-03-13       Impact factor: 3.411

3.  High-throughput living cell-based optical biosensor for detection of bacterial lipopolysaccharide (LPS) using a red fluorescent protein reporter system.

Authors:  Hui Jiang; Donglei Jiang; Jingdong Shao; Xiulan Sun; Jiasheng Wang
Journal:  Sci Rep       Date:  2016-11-14       Impact factor: 4.379

4.  Relationship between bronchoalveolar lavage fluid and plasma endotoxin activity in calves with bronchopneumonia.

Authors:  Yasunobu Nishi; Kenji Tsukano; Marina Otsuka; Masakazu Tsuchiya; Kazuyuki Suzuki
Journal:  J Vet Med Sci       Date:  2019-06-12       Impact factor: 1.267

5.  Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence.

Authors:  John C Marshall; Paul M Walker; Debra M Foster; David Harris; Melanie Ribeiro; Jeff Paice; Alexander D Romaschin; Anastasia N Derzko
Journal:  Crit Care       Date:  2002-05-02       Impact factor: 9.097

6.  Mode of renal replacement therapy determines endotoxemia and neutrophil dysfunction in chronic kidney disease.

Authors:  Sandra Lemesch; Werner Ribitsch; Gernot Schilcher; Walter Spindelböck; Hildegard Hafner-Gießauf; Gunther Marsche; Lisa Pasterk; Doris Payerl; Bianca Schmerböck; Monika Tawdrous; Alexander R Rosenkranz; Philipp Stiegler; Gerd Kager; Seth Hallström; Karl Oettl; Katharina Eberhard; Angela Horvath; Bettina Leber; Vanessa Stadlbauer
Journal:  Sci Rep       Date:  2016-10-04       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.